COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES

Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease. 提供了抗人tau抗体的剂量方案和制剂。这些制剂和剂量方案可用于治疗tau蛋白病,如进行性核上性麻痹和阿尔茨海默病。...

Full description

Saved in:
Bibliographic Details
Main Authors BURTON LORI S, QUAN YONG, BURGESS MICHAEL FRANS, HUANG MASANO TLANECI, TIRUCHERAI GIRIDHAR
Format Patent
LanguageChinese
English
Published 07.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease. 提供了抗人tau抗体的剂量方案和制剂。这些制剂和剂量方案可用于治疗tau蛋白病,如进行性核上性麻痹和阿尔茨海默病。
AbstractList Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease. 提供了抗人tau抗体的剂量方案和制剂。这些制剂和剂量方案可用于治疗tau蛋白病,如进行性核上性麻痹和阿尔茨海默病。
Author BURGESS MICHAEL FRANS
BURTON LORI S
TIRUCHERAI GIRIDHAR
QUAN YONG
HUANG MASANO TLANECI
Author_xml – fullname: BURTON LORI S
– fullname: QUAN YONG
– fullname: BURGESS MICHAEL FRANS
– fullname: HUANG MASANO TLANECI
– fullname: TIRUCHERAI GIRIDHAR
BookMark eNrjYmDJy89L5WQwdPb3DfAP9gzx9PcLVnD0c1HwdQ3x8HcJVnDzD1IICXJ1DPH0c1cIcQz1D3AM8fB0DeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGBubmBkamxo7GxKgBAGoLKIQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 用于治疗TAU蛋白病的组合物和方法
ExternalDocumentID CN110770253A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN110770253A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:25:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN110770253A3
Notes Application Number: CN201780091913
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200207&DB=EPODOC&CC=CN&NR=110770253A
ParticipantIDs epo_espacenet_CN110770253A
PublicationCentury 2000
PublicationDate 20200207
PublicationDateYYYYMMDD 2020-02-07
PublicationDate_xml – month: 02
  year: 2020
  text: 20200207
  day: 07
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies SQUIBB BRISTOL MYERS COMPANY
RelatedCompanies_xml – name: SQUIBB BRISTOL MYERS COMPANY
Score 3.3766334
Snippet Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200207&DB=EPODOC&locale=&CC=CN&NR=110770253A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH_MKepNp6LzgwrSW7Fd03U9FOnS1k7oB1smu42lTVEP3XAVwb_eJHTOi95CAi_Jg1_eR94HwJ3eX5hmYQw02qOlhgxENUcvkFaaRpEzrpNTJvwdcdKPpuhpZs1a8LbJhZF1Qj9lcUSOqJzjvZbv9WrrxPJlbOX6nr7yqeVDSFxfbaxjEXGg26o_dIMs9VOsYuziRE3GrjBzbC7fTW8HdoUaLersB89DkZWy-i1SwiPYyzi1qj6G1tdLBw7wpvNaB_bj5sObDxvsrU_AwGmcpZORzPtVvMRX4oBEqT9RuCGnkHHgkVHyqBBvmmYeibiadwq3YUBwpPG95z8XneNke0zzDNrVsmLnoCwWtDCFv04vEbIQG9CC9lCuO8wunJ7FLqD7N53uf4uXcCiYJqOQ7Sto1-8f7JoL2ZreSO58A5bSe8k
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUYP4NROzt8WNFQYPixnd5lDWLVAMb4SyEvUBiMyY-NfbNkN80bemTa7tJde73_U-AG7N1tS2M6ttsAabG8hCzOiYGTLmtpXNuLDJGZf-jpi0ohF6HDfHJXjb5MKoOqGfqjiikKiZkPdcvderrRPLV7GV6zv2KqaW9yF1fb1AxzLiwHR0v-sGaeInWMfYxUQnA1fCHEfod9vbgV1HQEJZZz947sqslNVvlRIewl4qqC3yIyh9vVShgjed16qwHxcf3mJYyN76GCycxGky7Km8X80jvhYHNEr8oSaAnEYHgUd75EGj3ihJPRoJM-8EbsKA4sgQe09-LjrBZHtM-xTKi-WC10CbTllmS3-dOUeoiXibZayBZmaHO1mn0eRnUP-bTv2_xWuoRDTuT_o98nQOB5KBKiLZuYBy_v7BL4XCzdmV4tQ3hsl-tA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITIONS+AND+METHODS+FOR+TREATING+TAUOPATHIES&rft.inventor=BURTON+LORI+S&rft.inventor=QUAN+YONG&rft.inventor=BURGESS+MICHAEL+FRANS&rft.inventor=HUANG+MASANO+TLANECI&rft.inventor=TIRUCHERAI+GIRIDHAR&rft.date=2020-02-07&rft.externalDBID=A&rft.externalDocID=CN110770253A